XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q1)Dec 28, 2024 | (FY)Sep 28, 2024 | (Q4)Sep 28, 2024 | (Q3)Jun 29, 2024 | (Q2)Mar 30, 2024 | (Q1)Dec 30, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jul 1, 2023 | (Q2)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -46.20%-105.08M | 1,560.99%107.47M | -42.11%47.06M | 2.52%175.49M | 29.84%-43.21M | 61.02%-71.87M | -90.29%6.47M | 1,451.56%81.28M | -18.26%171.18M | -61.58M |
Net income from continuing operations | -12.67%-44.56M | -185.82%-23.38M | -160.21%-9.92M | -16.40%60.65M | -9.60%-34.55M | -30.71%-39.55M | -82.87%27.24M | -71.55%16.48M | -41.01%72.55M | ---31.53M |
Operating gains losses | -173.77%-45K | -92.75%464K | -93.45%412K | -140.00%-36K | -75.89%27K | 916.67%61K | 1,272.53%6.4M | 3,127.18%6.29M | -109.80%-15K | --112K |
Depreciation and amortization | -1.12%8.24M | -3.12%33.08M | 0.99%8.66M | 1.26%8.25M | -12.09%7.84M | -2.03%8.33M | 10.96%34.14M | 8.67%8.57M | 15.31%8.14M | --8.92M |
Deferred tax | -42.48%-11.95M | 154.19%3.43M | 251.82%11.24M | 2,271.03%18.89M | ---18.31M | -531.53%-8.39M | -356.69%-6.33M | -19,384.21%-7.4M | -172.56%-870K | --0 |
Other non cash items | -3.39%541K | 4.33%2.19M | -2.68%544K | -0.75%531K | 10.32%556K | 11.55%560K | 5.95%2.1M | 12.02%559K | 7.65%535K | --504K |
Change In working capital | -65.99%-59.29M | 218.34%81.63M | -35.81%34.71M | -4.54%84.28M | 96.21%-1.64M | 78.75%-35.72M | 50.94%-68.98M | 171.29%54.07M | 18.85%88.29M | ---43.22M |
-Change in receivables | 127.28%15.38M | -216.04%-18.68M | -106.44%-1.26M | -22.04%-13.81M | -215.24%-10.38M | 720.83%6.77M | 311.27%16.1M | 1,193.10%19.5M | 18.88%-11.32M | --9.01M |
-Change in inventory | -65.83%-36.8M | 58.07%85.88M | -38.86%76.25M | 34.95%76.88M | 28.02%-45.06M | 65.73%-22.19M | 137.95%54.33M | 3,990.65%124.72M | 511.71%56.97M | ---62.6M |
-Change in prepaid assets | 244.71%5.06M | 70.60%-1.02M | 60.91%9.89M | -105.32%-1.13M | 74.33%-6.28M | 45.59%-3.5M | -134.82%-3.47M | -19.09%6.15M | 89.50%21.28M | ---24.47M |
-Change in payables and accrued expense | -118.04%-44.51M | 101.93%2.44M | 40.92%-56.58M | -11.33%20.57M | 52.39%58.87M | 78.01%-20.41M | -531.11%-126.78M | -12.13%-95.77M | -75.62%23.2M | --38.63M |
-Change in other current assets | -63.85%1.44M | 168.68%6.86M | 126.64%300K | 151.64%1.1M | 147.24%1.48M | 210.55%3.98M | 21.15%-9.99M | 65.26%-1.13M | 52.74%-2.13M | ---3.13M |
-Change in other working capital | 140.17%145K | 645.09%6.15M | 937.24%6.1M | 141.01%670K | 60.63%-261K | -158.04%-361K | 116.20%825K | -9.40%588K | 51.91%278K | ---663K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -46.20%-105.08M | 1,560.99%107.47M | -42.11%47.06M | 2.52%175.49M | 29.84%-43.21M | 61.02%-71.87M | -90.29%6.47M | 1,451.56%81.28M | -18.26%171.18M | ---61.58M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 56.56%-4.65M | 10.23%-47.16M | -10.95%-12.92M | 40.58%-10.28M | -34.78%-13.27M | 22.18%-10.7M | 62.20%-52.54M | 84.01%-11.64M | 22.32%-17.31M | -9.84M |
Net PPE purchase and sale | 56.44%-4.68M | -22.47%-47.24M | -9.08%-12.92M | 13.35%-10.32M | -37.95%-13.27M | -106.16%-10.74M | -21.59%-38.58M | -90.63%-11.84M | -2.65%-11.91M | ---9.62M |
Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | 85.56%-15.55M | --0 | 47.48%-5.61M | ---1.4M |
Net other investing changes | -25.00%30K | -94.90%81K | -98.03%4K | -84.13%33K | --4K | --40K | 288.97%1.59M | --203K | --208K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 56.56%-4.65M | 10.23%-47.16M | -10.95%-12.92M | 40.58%-10.28M | -34.78%-13.27M | 22.18%-10.7M | 62.20%-52.54M | 84.01%-11.64M | 22.32%-17.31M | ---9.84M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -63.89%12.84M | 33.19%-7.22M | 99.78%-73K | 30.69%-99.21M | -27.01%56.52M | -59.86%35.55M | 93.20%-10.8M | -1,561.83%-33.65M | -211.34%-143.14M | 77.43M |
Net issuance payments of debt | -64.23%12.87M | 23.21%-6.22M | 99.56%-145K | 30.76%-99.03M | -27.86%56.98M | -59.57%35.98M | 0.00%-8.1M | -1,530.86%-33.03M | -204.15%-143.03M | --78.98M |
Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other financing activities | 92.06%-34K | 63.09%-998K | 111.48%72K | -56.90%-182K | 70.17%-460K | -2.15%-428K | ---2.7M | ---627K | ---116K | ---1.54M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -63.89%12.84M | 33.19%-7.22M | 99.78%-73K | 30.69%-99.21M | -27.01%56.52M | -59.86%35.55M | 93.20%-10.8M | -1,561.83%-33.65M | -211.34%-143.14M | --77.43M |
Net cash flow | ||||||||||
Beginning cash position | 95.79%108.51M | -50.65%55.42M | 283.11%74.44M | -3.05%8.44M | 211.93%8.39M | -50.65%55.42M | -67.31%112.29M | -89.94%19.43M | -83.26%8.7M | --2.69M |
Current changes in cash | -106.03%-96.89M | 193.34%53.09M | -5.34%34.07M | 515.17%66M | -99.30%42K | 57.09%-47.03M | 75.40%-56.87M | 144.52%35.99M | -92.40%10.73M | --6.01M |
End cash Position | 38.37%11.62M | 95.79%108.51M | 95.79%108.51M | 283.11%74.44M | -3.05%8.44M | 211.93%8.39M | -50.65%55.42M | -50.65%55.42M | -89.94%19.43M | --8.7M |
Free cash flow | -32.86%-109.76M | 287.57%60.22M | -50.84%34.14M | 3.71%165.18M | 20.13%-56.48M | 56.54%-82.61M | -191.95%-32.11M | 687.82%69.44M | -19.48%159.27M | ---70.71M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |